192 related articles for article (PubMed ID: 9676708)
1. Evidence for cross-reactivity between antigen derived from Trypanosoma cruzi and myelin basic protein in experimental Chagas disease.
Al-Sabbagh A; Garcia CA; Diaz-Bardales BM; Zaccarias C; Sakurada JK; Santos LM
Exp Parasitol; 1998 Jul; 89(3):304-11. PubMed ID: 9676708
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
Mikhail KS; Rowland EC
J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
[TBL] [Abstract][Full Text] [Related]
5. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease.
Rowland EC; Mikhail KS; McCormick TS
J Parasitol; 1992 Jun; 78(3):557-61. PubMed ID: 1375959
[TBL] [Abstract][Full Text] [Related]
6. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to experimental Trypanosoma rangeli infection and its implications for immunodiagnosis of South American trypanosomiasis.
Guhl F; Hudson L; Marinkelle CJ; Morgan SJ; Jaramillo C
Acta Trop; 1985 Dec; 42(4):311-8. PubMed ID: 2868633
[TBL] [Abstract][Full Text] [Related]
9. Effect of repetitiveness on the immunogenicity and antigenicity of Trypanosoma cruzi FRA protein.
Valiente-Gabioud AA; Veaute C; Perrig M; Galan-Romano FS; Sferco SJ; Marcipar IS
Exp Parasitol; 2011 Mar; 127(3):672-9. PubMed ID: 21118687
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
[TBL] [Abstract][Full Text] [Related]
11. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
Wallace A; Sanchez G; Venegas J; Solari A
Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
[TBL] [Abstract][Full Text] [Related]
12. Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens.
Oliveira EC; Fujisawa MM; Hallal Longo DE; Farias AS; Contin Moraes J; Guariento ME; de Almeida EA; Saad MJ; Langone F; Toyama MH; Andreollo NA; Santos LM
Neuroimmunomodulation; 2009 Jan; 16(1):54-62. PubMed ID: 19077446
[TBL] [Abstract][Full Text] [Related]
13. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
Xu BX; Powell MR
J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
[TBL] [Abstract][Full Text] [Related]
15. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.
Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ
J Clin Microbiol; 2006 Feb; 44(2):291-6. PubMed ID: 16455872
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
17. Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsin.
Matsumoto SC; Labovsky V; Roncoroni M; Guida MC; Giménez L; Mitelman J; Gori H; Jurgelevicius R; Grillo A; Manfredi P; Levin MJ; Paveto C
FASEB J; 2006 Mar; 20(3):550-2. PubMed ID: 16423878
[TBL] [Abstract][Full Text] [Related]
18. Human humoral immunity to hsp70 during Trypanosoma cruzi infection.
Engman DM; Dragon EA; Donelson JE
J Immunol; 1990 May; 144(10):3987-91. PubMed ID: 2110215
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
Zúñiga E; Montes C; Barbieri G; Gruppi A
Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
[TBL] [Abstract][Full Text] [Related]
20. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi.
Tadokoro CE; Vallochi AL; Rios LS; Martins GA; Schlesinger D; Mosca T; Kuchroo VK; Rizzo LV; Abrahamsohn IA
J Autoimmun; 2004 Sep; 23(2):103-15. PubMed ID: 15324929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
